LLY Up Around 6% Post Robust Q2 Results: Buy, Sell or Hold the Stock?
Eli Lilly and Company‘s LLY stock has risen 5.8% since it announced solid second-quarter results on Aug. 5. Lilly’s earnings and revenues comfortably exceeded estimates. Revenues rose 48% year over year…




